Inventor · disambiguated record
Peter Sejer Andersen
Also filed as: ANDERSEN PETER · ANDERSEN PETER C · ANDERSEN PETER S · ANDERSEN PETER SEJER
8 granted patents·17 pending applications·168 citations·filing 1998–2023
85Inventor score
Top patents by PatentIndex Score
25 records- 0191US10058610B2Methods for treating cancer by administering humanized pan-HER antibody compositionsSYMPHOGEN AS·Filed 2016·Granted Aug 28, 2018·9 cites·20 claims
- 0291US7749697B2Method for linking sequences of interestSYMPHOGEN AS·Filed 2004·Granted Jul 6, 2010·134 cites·29 claims
- 0377US9527913B2Humanized pan-HER antibody compositionsSYMPHOGEN AS·Filed 2013·Granted Dec 27, 2016·4 cites·8 claims
- 0473US6436409B1Polynucleotide functionally coding for the LHP protein from Mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the samePASTEUR INSTITUT·Filed 1998·Granted Aug 20, 2002·18 cites·26 claims
- 0563US10059751B2Peptide combinations and uses thereof in treating dust mite allergyALK ABELLO AS·Filed 2014·Granted Aug 28, 2018·1 cites·15 claims
- 0659US2025009880A1Immune cell therapy of pd-l1 positive cancersVITA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0757US8288109B2Procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell lineRASMUSSEN LONE KJAER·Filed 2005·Granted Oct 16, 2012·2 cites·29 claims
- 0857US2018344846A1Humanized pan-her antibody compositionsSYMPHOGEN AS·Filed 2018·Application pending·0 cites
- 0956US2025325658A1Peanut allergen compositionsALK ABELLO AS·Filed 2023·Application pending·0 cites
- 1055US2025017969A1Preparation of engineered myeloid cellsVITA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1154US9029091B2Procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell lineSYMPHOGEN AS·Filed 2012·Granted May 12, 2015·0 cites·13 claims
- 1252US2022411825A1Method of engineering hypoimmunogenic muscle precursor cellsVITA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1347US9040496B2Reduction of ALMS1 gene expression or inhibition of altröm protein to induce cardiomyocyte proliferationUNIV JOHNS HOPKINS·Filed 2013·Granted May 26, 2015·0 cites·6 claims
- 1447US2022073883A1Compositions and methods for generation of heart field-specific progenitor cellsUNIV JOHNS HOPKINS·Filed 2019·Application pending·0 cites
- 1545US2020359887A1Oct radiomic features for differentiation of early malignant melanoma from benign nevusUNIV WAYNE STATE·Filed 2020·Application pending·0 cites
- 1645US2013004499A1Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosaSYMPHOGEN AS·Filed 2011·Application pending·0 cites
- 1743US2013004500A1Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosaSYMPHOGEN AS·Filed 2011·Application pending·0 cites
- 1843US2007225338A1Juvenile Hormone Analogs for Control of Leafhopper and Treehopper PestsMIZELL RUSSELL F III·Filed 2005·Application pending·0 cites
- 1943US2013045207A1Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosaSYMPHOGEN AS·Filed 2011·Application pending·0 cites
- 2043US2013022604A1Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosaSYMPHOGEN AS·Filed 2011·Application pending·0 cites
- 2143US2013022603A1Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosaSYMPHOGEN AS·Filed 2011·Application pending·0 cites
- 2239US2022041990A1Methods, compositions, and kits for producing skeletal muscle stem cells and treating disordersUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 2339US2021214794A1Biomarker methods for treatment of atopic disease by immunotherapyALD ABELLO AS·Filed 2019·Application pending·0 cites
- 2438US2010310558A1Method for Linking Sequences of InterestSYMPHOGEN AS·Filed 2010·Application pending·0 cites
- 2531US2002150914A1Recombinant antibodies from a phage display library, directed against a peptide-MHC complexUINV KOBENHAVNS·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Sejer Andersen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →